Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Nihon Shokakibyo Gakkai Zasshi ; 109(6): 936-43, 2012 Jun.
Artigo em Japonês | MEDLINE | ID: mdl-22688170

RESUMO

A 74-year-old man was admitted to our hospital with abdominal pain and bloody stool. The patients' history showed that he had had occlusion of the proximal common trunk of the celiac artery (CA) and the superior mesenteric artery (SMA). The inferior mesenteric artery (IMA), and the marginal artery of the colon had developed well. It was assumed that almost the entire visceral blood might be supplied by the IMA to the CA and the SMA. Our investigation revealed that the patient had advanced cancer of the sigmoid colon, which had caused intestinal obstruction. Sigmoidectomy was performed with care to avoid injuring the IMA and the marginal arcade artery. Normal hemodynamics were successfully established followed by sigmoidectomy, and cure was obtained in this patient.


Assuntos
Adenocarcinoma/cirurgia , Neoplasias do Colo Sigmoide/cirurgia , Idoso , Artéria Celíaca/patologia , Circulação Colateral , Colo Sigmoide/cirurgia , Humanos , Masculino , Artéria Mesentérica Superior/patologia
2.
Leuk Lymphoma ; 43(3): 641-3, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12002772

RESUMO

A 54-year-old man diagnosed with IgD myeloma (stage IIIA) in complete remission (CR) received peripheral blood stem cell transplantation (PBSCT) twice with an interval of 4 months using high-dose melphalan 200mg/m2. However 9 months after the second PBSCT, he was readmitted because of lumbago, lower left hemiparesis, speech disturbance and left facial nerve palsy. A lumbar puncture revealed myeloma cells in the cerebrospinal fluid (CSF). The patient did not respond to any salvage chemotherapy and died of sepsis 27 months after the initial diagnosis. The findings in this patient suggest that another treatment modality including prophylactic intrathecal injection of an anti-cancer drug as well as allogeneic cell therapy is probably necessary in patients with high-risk IgD myeloma.


Assuntos
Neoplasias Meníngeas/etiologia , Mieloma Múltiplo/patologia , Mieloma Múltiplo/terapia , Transplante de Células-Tronco , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Evolução Fatal , Humanos , Imunoglobulina D , Masculino , Neoplasias Meníngeas/diagnóstico , Pessoa de Meia-Idade , Mieloma Múltiplo/imunologia , Recidiva
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA